Tolleson Wealth Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Tolleson Wealth Management’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,089	Closed	-$205K	–	70
2022 Q2	$205K	Buy	+7,089	New	+$212K	0.06%	68
2022 Q1	–	Sell	-5,334	Closed	-$234K	–	73
2021 Q4	$234K	Hold	5,334	–	–	0.06%	66
2021 Q3	$270K	Hold	5,334	–	–	0.08%	58
2021 Q2	$278K	Hold	5,334	–	–	0.07%	65
2021 Q1	$244K	Hold	5,334	–	–	0.07%	69
2020 Q4	$245K	Hold	5,334	–	–	0.08%	61
2020 Q3	$208K	Buy	+5,334	New	+$205K	0.08%	60

Other funds holding IDNA

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Tolleson Wealth Management's IDNA Position: Q3 2022 in Review

Tolleson Wealth Management sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2022, closing a stake of 7,089 shares — an estimated $205K sold.

Tolleson Wealth Management first reported a position in IDNA in Q3 2020 and held it in 7 quarters. The position peaked at $278K in Q2 2021. 67 funds tracked by Wall St. Rank hold IDNA as of Q3 2022.

Tolleson Wealth Management reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q3 2022 after selling out during the quarter.
Tolleson Wealth Management sold 7,089 iShares Genomics Immunology and Healthcare ETF shares in Q3 2022, an estimated $205K.
Tolleson Wealth Management first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2020 and held it in 7 quarters.
Tolleson Wealth Management's iShares Genomics Immunology and Healthcare ETF position peaked at $278K in Q2 2021.
67 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2022.

Based on Tolleson Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.